Back

Epigenetic therapy reduces angiotensin-II induced cardiac hypertrophy and fibrosis

29 April 2017 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Basic Science - Cellular biology HFpEF - Heart failure with preserved ejection fraction HFA Premium Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Adam Russell-Hallinan

Queen's University of Belfast, Belfast (United Kingdom of Great Britain & Northern Ireland)

9 More presentations in this session

Presentation thumbnail
Effects of chronic ACE inhibitor treatment on a translational model of heart failure with preserved ejection fraction
Miss N. Harouki (Issy Les Moulineaux, FR)
Abstract
Presentation thumbnail
Increased plasma clusterin levels in patients with left ventricular remodeling after myocardial infarction has cardiac origin and is due to a defect in proteasome activity
Doctor A. Turkieh (Lille, FR)
Abstract
Presentation thumbnail
Angiotensin 1-7 might be a new solution in the treatment of chronic heart failure
Doctor A. Kazak (Minsk, BY)
Abstract
Presentation thumbnail
SIRT1 protects the heart from endoplasmic reticulum stress-induced apoptosis through eIF2a deacetylation
Ms J. Pires Da Silva (Chatenay-Malabry, FR)
Abstract
Presentation thumbnail
Influence of iron availability in the normoxic versus hypoxic conditions on the morphology and atrophy of skeletal myocytes.
Doctor K. Kobak (Oklahoma City, US)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Basic Science - Cellular biology

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources